![Efthymios Deliargyris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 168 995 $ au 30/06/2026
Efthymios N.
Deliargyris is currently Chief Medical Officer at CytoSorbents Corp.
since 2020.
Formerly, served as Chief Medical Officer at PLx Pharma, Inc. from 2018 to 2020, Director-Cardiology & Interventional Cardiology at Athens Medical Center SA from 2004 to 2010, and Assistant Professor at Wake Forest University from 2001 to 2004.
Education includes a doctorate from National & Kapodistrian University of Athens.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CYTOSORBENTS CORPORATION 0,72 % | 01/06/2026 | 451 859 ( 0,72 % ) | 168 995 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CYTOSORBENTS CORPORATION | Directeur Technique/Scientifique/R&D | 01/05/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| PLX PHARMA WINDDOWN CORP. | Directeur Technique/Scientifique/R&D | 30/04/2020 |
| ATHENS MEDICAL C.S.A. | Corporate Officer/Principal | 01/01/2010 |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2004 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Athens Medical Center SA
 Athens Medical Center SA Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National & Kapodistrian University of Athens
 National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoSorbents Corp.
 CytoSorbents Corp. Medical SpecialtiesHealth Technology Develops products to support healthcare professionals in the treatment of complex medical conditions | Health Technology |
PLx Pharma, Inc.
 PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops liquid-filled aspirin capsules for pain management | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
